PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 105 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,000 | – | 3,136 | +25.4% | 0.00% | – |
| Q2 2023 | $0 | – | 2,500 | +1073.7% | 0.00% | – |
| Q3 2022 | $0 | – | 213 | +113.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 100 | -91.9% | 0.00% | – |
| Q4 2021 | $5,000 | -90.0% | 1,242 | -90.4% | 0.00% | – |
| Q2 2021 | $50,000 | +400.0% | 12,975 | +226.0% | 0.00% | – |
| Q1 2021 | $10,000 | -9.1% | 3,980 | -10.5% | 0.00% | – |
| Q4 2020 | $11,000 | – | 4,449 | +444800.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q2 2020 | $7,000 | +133.3% | 2,271 | +70.5% | 0.00% | – |
| Q1 2020 | $3,000 | -75.0% | 1,332 | -48.8% | 0.00% | – |
| Q2 2019 | $12,000 | +100.0% | 2,601 | +158.8% | 0.00% | – |
| Q3 2018 | $6,000 | +500.0% | 1,005 | +552.6% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 154 | +2.7% | 0.00% | – |
| Q4 2017 | $1,000 | -94.4% | 150 | -95.2% | 0.00% | – |
| Q3 2017 | $18,000 | -37.9% | 3,126 | -75.2% | 0.00% | – |
| Q4 2015 | $29,000 | – | 12,586 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 5,628,585 | $5,853,728 | 5.06% |
| Aquilo Capital Management, LLC | 4,552,876 | $4,734,991 | 1.78% |
| BVF INC/IL | 5,080,320 | $5,283,533 | 0.22% |
| Soleus Capital Management, L.P. | 1,000,000 | $1,040,000 | 0.15% |
| Cutter & CO Brokerage, Inc. | 378,479 | $393,618 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,220,798 | $1,269,630 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 365,047 | $380 | 0.05% |
| Annandale Capital, LLC | 67,000 | $70 | 0.02% |
| WEALTH EFFECTS LLC | 21,700 | $22,568 | 0.01% |
| Sigma Planning Corp | 343,934 | $357,691 | 0.01% |